TechNavio's analysts forecast the Global Atherectomy and Thrombectomy Devices market to grow at a CAGR of 9.36 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of abdominal aortic aneurysm and peripheral artery disease. The Global Atherectomy and Thrombectomy Devices market has also been witnessing the increase in demand for minimally invasive procedures. However, the lack of awareness about peripheral vascular disease among patients could pose a challenge to the growth of this market.
TechNavio's report, the Global Atherectomy and Thrombectomy Devices Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Atherectomy and Thrombectomy Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Bayer AG, Boston Scientific Corp., Covidien plc, Cardiovascular Systems Inc., and Spectranetics Corp.
Other vendors mentioned in the report are Argon Medical Devices Inc., Accellent Inc. AtheroMed Inc., C.R. Bard Inc., Cod Man Neuro, (DePuy Orthopaedics Inc.), Cook Medical Inc. Edwards Lifesciences Corp., IDEV Technologies Inc., Lazarius Effect, Medtronic Inc., NexGen Medical Systems Inc., Reverse Medical Corp., St. Jude Medical Inc., and Teleflex Medical Inc.
Key questions answered in this report:
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
06. Global Atherectomy and Thrombectomy Market
06.1 Market Overview
06.2 Market Size and Forecast
07. Market Segmentation by Product Category
07.1 Atherectomy Devices
07.2 Thrombectomy Devices
07.3 Five Forces Analysis
08. Geographical Segmentation
08.1 Atherectomy and Thrombectomy Devices Market in the Americas
Market Size and Forecast
08.2 Atherectomy and Thrombectomy Devices Market in the EMEA
Market Size and Forecast
08.3 Atherectomy and Thrombectomy Devices Market in the APAC
Market Size and Forecast
09. Global Atherectomy Market
09.1 Market Overview
09.2 Market Size and Forecast
10. Market Segmentation by Product Type
11. Geographical Segmentation
11.1 Key Leading Countries
12. Global Thrombectomy Devices Market
12.1 Market Overview
12.2 Market Size and Forecast
13. Market Segmentation by Procedure
14. Geographical Segmentation
14.1 Key Leading Countries
15. Buying Criteria
16. Market Growth Drivers
17. Drivers and their Impact
18. Market Challenges
19. Impact of Drivers and Challenges
20. Market Trends
21. Trends and their Impact
22. Vendor Landscape
22.1 Competitive Scenario
22.1.1 Key News
22.1.2 Mergers and Acquisitions
22.2 Market Share Analysis 2013
22.3 Other Prominent Vendors
23. Key Vendor Analysis
23.1 Bayer AG
23.1.1 Business Overview
23.1.2 Business Segmentation
23.1.3 Key Information
23.1.4 SWOT Analysis
23.2 Boston Scientific Corp.
23.2.1 Business Overview
23.2.2 Business Segmentation
23.2.3 Key Information
23.2.4 SWOT Analysis
23.3 Covidien plc
23.3.1 Business Overview
23.3.2 Business Segmentation
23.3.3 Key Information
23.3.4 SWOT Analysis
23.4 Cardiovascular Systems Inc.
23.4.1 Business Overview
23.4.2 Key Information
23.4.3 SWOT Analysis
23.5 Spectranetics Corp.
23.5.1 Business Overview
23.5.2 Business Segmentation
23.5.3 Key Information
23.5.4 SWOT Analysis
24. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Atherectomy and Thrombectomy Devices Market 2013-2018 (US$ million)
Exhibit 3: Global Atherectomy and Thrombectomy Devices Market Segmentation by Product Category
Exhibit 4: Global Atherectomy and Thrombectomy Devices Market Segmentation by Product Category 2013
Exhibit 5: Global Atherectomy and Thrombectomy Devices Market by Geographical Segmentation 2013
Exhibit 6: Atherectomy and Thrombectomy Devices Market in the Americas 2013-2018 (US$ million)
Exhibit 7: Atherectomy and Thrombectomy Devices Market in the EMEA 2013-2018 (US$ million)
Exhibit 8: Atherectomy and Thrombectomy Devices Market in the APAC 2013-2018 (US$ million)
Exhibit 9: Global Atherectomy Devices Market 2013-2018 (US$ million)
Exhibit 10: Global Atherectomy Devices Market Segmentation by Product Type
Exhibit 11: Global Atherectomy Devices Market by Geographical Segmentation 2013
Exhibit 12: Global Thrombectomy Devices Market 2013-2018 (US$ million)
Exhibit 13: Global Thrombectomy Devices Market Segmentation by Procedure
Exhibit 14: Global Thrombectomy Devices Market by Geographical Segmentation 2013
Exhibit 15: Business Segmentation of Bayer AG
Exhibit 16: Business Segmentation of Boston Scientific Corp.
Exhibit 17: Business Segmentation of Covidien plc
Exhibit 18: Business Segmentation of Spectranetics Corp.